OSI-461

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OSI-461, covering 2011-10-17 to 2011-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]